Sepsis: the evolution of molecular pathogenesis concepts and clinical management
Zhongxue Feng,
No information about this author
Lijun Wang,
No information about this author
Jing Yang
No information about this author
et al.
MedComm,
Journal Year:
2025,
Volume and Issue:
6(3)
Published: Feb. 23, 2025
Abstract
The
mortality
rate
of
sepsis
is
approximately
22.5%,
accounting
for
19.7%
the
total
global
mortality.
Since
Lewis
Thomas
proposed
in
1972
that
“it
our
response
makes
disease
(sepsis)”
rather
than
invading
microorganisms,
numerous
drugs
have
been
developed
to
suppress
“overwhelming”
inflammatory
response,
but
none
them
has
achieved
desired
effect.
Continued
failure
led
investigators
question
whether
deaths
septic
patients
are
indeed
caused
by
uncontrolled
inflammation.
Here,
we
review
history
clinical
trials
based
on
evolving
concepts
pathogenesis
over
past
half
century,
summarize
factors
these
historical
and
prerequisites
success
future
drugs,
propose
basic
principles
preclinical
research
ensure
successful
translation.
strategy
targeting
like
attempting
eliminate
invaders
suppressing
host's
armed
forces,
which
logically
untenable.
Sepsis
may
not
be
complex;
rather,
result
a
fight
microbes
when
force
an
pathogen
overwhelms
defenses.
Thus,
strengthening
body's
defense
forces
instead
correct
overcome
sepsis.
Language: Английский
Intestinal Microbiota Dysbiosis Role and Bacterial Translocation as a Factor for Septic Risk
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(5), P. 2028 - 2028
Published: Feb. 26, 2025
The
human
immune
system
is
closely
linked
to
microbiota
such
as
a
complex
symbiotic
relationship
during
the
coevolution
of
vertebrates
and
microorganisms.
transfer
microorganisms
from
mother's
newborn
begins
before
birth
gestation
considered
initial
phase
intestinal
(IM).
gut
an
important
site
where
can
establish
colonies.
IM
contains
polymicrobial
communities,
which
show
interactions
with
diet
host
immunity.
tendency
towards
dysbiosis
influenced
by
local
but
also
extra-intestinal
factors
inflammatory
processes,
infections,
or
septic
state
that
aggravate
it.
Pathogens
could
trigger
response,
proinflammatory
responses.
In
addition,
changes
in
influence
community
structure
additional
translocation
pathogenic
non-pathogenic
bacteria.
Finally,
inflammation
has
been
found
be
factor
growth
microorganisms,
particularly
its
role
sepsis.
aim
this
article
able
detect
current
knowledge
mechanisms
lead
cause
bacterial
risk
infection
vice
versa.
Language: Английский
Subphenotypes and the De Ritis ratio for mortality risk stratification in sepsis-associated acute liver injury: a retrospective cohort study
Lars Palmowski,
No information about this author
Britta Westhus,
No information about this author
Andrea Witowski
No information about this author
et al.
EClinicalMedicine,
Journal Year:
2025,
Volume and Issue:
82, P. 103173 - 103173
Published: March 29, 2025
Language: Английский
Melatonin-Mediated Protection against Sepsis-Induced Organ Dysfunction
IntechOpen eBooks,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Sepsis-induced
organ
dysfunction
represents
a
critical
challenge
in
intensive
care
medicine,
characterized
by
complex
pathophysiological
mechanisms
that
can
lead
to
multiple
failure
and
death.
This
review
examines
the
fundamental
underlying
sepsis-induced
explores
therapeutic
potential
of
melatonin,
multifaceted
molecule
with
potent
antioxidant
anti-inflammatory
properties.
We
analyzed
pathways
involved
damage
during
sepsis,
including
inflammatory
cascades,
oxidative
stress,
mitochondrial
dysfunction,
endothelial
injury.
Special
attention
is
given
melatonin’s
protective
effects
on
various
systems,
cardiac,
pulmonary,
renal,
hepatic,
central
nervous
system
function
sepsis.
Recent
evidence
suggests
ability
modulate
these
pathways,
combined
its
excellent
safety
profile,
makes
it
promising
agent
sepsis
management.
Understanding
applications
may
provide
new
strategies
for
improving
outcomes
septic
patients.
Language: Английский
Organ crosstalk and dysfunction in Sepsis: harnessing emerging biotechnologies for future breakthroughs
Annals of Intensive Care,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: Oct. 23, 2024
Language: Английский
Development and validation of clinical criteria for critical illness-associated immune dysfunction: based on the MIMIC-IV database
Yujie Zhou,
No information about this author
Linfeng Tao,
No information about this author
Shengsheng Yang
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2024,
Volume and Issue:
11
Published: Dec. 11, 2024
Background
Critical
illness-associated
immune
dysfunction
(CIID)
is
prevalent
in
the
ICU
and
frequently
resulted
uncontrollably
responses.
immunological
understood
to
be
important,
although
there
are
currently
no
clinically
accepted
diagnostic
criteria
for
it.
Given
this,
we
examined
literature
developed
an
initial
criterion
that
validated
using
MIMIC-IV
database.
Methods
We
searched
related
last
32
years.
Patients
admitted
first
time
were
selected
by
screening
Different
used
categorize
patients
into
groups
(ID)
non-immune
(NID).
Within
ID
group,
subdivided
three
subgroups:
hyperinflammatory
(HI),
immunosuppression
(IS),
a
subgroup
combining
hyperinflammation
(HI+IS).
The
APACHE
II
was
measure
patients’
severity.
association
between
mortality
after
30
or
180
days
evaluated
through
KM
curves
COX
regression
analysis.
Results
By
summarizing
relevant
literature,
proposed
criteria.
analysis
included
43,965
patients,
with
approximately
77%
meeting
CIID.
observed
possessed
higher
scores
differences
peak
among
subgroups.
When
comparing
30-day
model,
it
evident
IS
had
lowest
risk
HI
greatest
accounting
all
covariates.
In
contrast,
highest
of
death,
those
when
long-term
mortality.
summary,
propose
validate
Subgroup
analyses
carried
out,
which
also
revealed
variations
groups.
Conclusion
confirmed
database,
demonstrating
scientifically
valid
reliable.
Language: Английский
Gut Microbiota and Liver Dysfunction in Sepsis: The Role of Inflammatory Mediators and Therapeutic Approaches
International Journal of Molecular Sciences,
Journal Year:
2024,
Volume and Issue:
25(24), P. 13415 - 13415
Published: Dec. 14, 2024
Sepsis
is
a
life-threatening
complication
caused
by
an
uncontrolled
immune
response
to
infection
that
can
lead
multi-organ
dysfunction,
including
liver
injury.
Recent
research
has
shown
the
critical
role
of
gut
microbiota
in
sepsis
pathogenesis,
with
gut–liver
axis
playing
crucial
disease
progression.
Mechanisms
such
as
disruption
barrier
and
injury
pathways
mediated
cytokines,
chemokines,
adhesion
molecules,
hydrogen
sulfide
(H2S).
substance
P
(SP)
have
been
focus
recent
studies.
Some
potential
biomarkers
microbiota-targeted
therapies
promise
emerging
tools
for
predicting
managing
sepsis.
This
review
describes
biomarker-driven
interventions
improve
outcomes.
Language: Английский